heart failure
CONCLUSION: In this small pilot study, ecadotril in doses of 50 to 400 mg twice       daily was generally well-tolerated and without severe short-term adverse effects        in patients with mild to moderate heart failure.
CONCLUSION: In this small pilot study, ecadotril in doses of 50 to 400 mg twice       daily was generally well-tolerated and without severe short-term adverse effects        in  @OBJECT$   @PREDICAT$  mild to moderate  @SUBJECT$ .